nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclosporine—ABCC10—Vincristine—muscle cancer	0.0619	0.0838	CbGbCtD
Cyclosporine—ABCC10—Etoposide—muscle cancer	0.0567	0.0768	CbGbCtD
Cyclosporine—ABCC3—Vincristine—muscle cancer	0.0389	0.0527	CbGbCtD
Cyclosporine—ABCC1—Dactinomycin—muscle cancer	0.0388	0.0525	CbGbCtD
Cyclosporine—ABCC10—Doxorubicin—muscle cancer	0.0387	0.0524	CbGbCtD
Cyclosporine—ABCC10—Methotrexate—muscle cancer	0.0375	0.0507	CbGbCtD
Cyclosporine—ABCC3—Etoposide—muscle cancer	0.0357	0.0483	CbGbCtD
Cyclosporine—ABCB11—Vincristine—muscle cancer	0.0336	0.0455	CbGbCtD
Cyclosporine—ABCG2—Dactinomycin—muscle cancer	0.026	0.0351	CbGbCtD
Cyclosporine—ABCC3—Doxorubicin—muscle cancer	0.0243	0.0329	CbGbCtD
Cyclosporine—ABCC1—Vincristine—muscle cancer	0.0239	0.0323	CbGbCtD
Cyclosporine—ABCC3—Methotrexate—muscle cancer	0.0236	0.0319	CbGbCtD
Cyclosporine—ABCC1—Etoposide—muscle cancer	0.0219	0.0296	CbGbCtD
Cyclosporine—ABCB11—Doxorubicin—muscle cancer	0.021	0.0285	CbGbCtD
Cyclosporine—ABCC2—Vincristine—muscle cancer	0.0177	0.0239	CbGbCtD
Cyclosporine—ABCC2—Etoposide—muscle cancer	0.0162	0.0219	CbGbCtD
Cyclosporine—ABCG2—Vincristine—muscle cancer	0.016	0.0216	CbGbCtD
Cyclosporine—ABCC1—Doxorubicin—muscle cancer	0.0149	0.0202	CbGbCtD
Cyclosporine—ABCG2—Etoposide—muscle cancer	0.0147	0.0198	CbGbCtD
Cyclosporine—ABCC1—Methotrexate—muscle cancer	0.0145	0.0196	CbGbCtD
Cyclosporine—SLCO1A2—Methotrexate—muscle cancer	0.0129	0.0175	CbGbCtD
Cyclosporine—SLCO1B1—Methotrexate—muscle cancer	0.0122	0.0165	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.0118	0.016	CbGbCtD
Cyclosporine—CYP3A7—Vincristine—muscle cancer	0.0118	0.016	CbGbCtD
Cyclosporine—ABCC2—Doxorubicin—muscle cancer	0.0111	0.015	CbGbCtD
Cyclosporine—ABCC2—Methotrexate—muscle cancer	0.0107	0.0145	CbGbCtD
Cyclosporine—ABCG2—Doxorubicin—muscle cancer	0.00999	0.0135	CbGbCtD
Cyclosporine—ABCG2—Methotrexate—muscle cancer	0.00968	0.0131	CbGbCtD
Cyclosporine—PPID—C-MYB transcription factor network—MYF6—muscle cancer	0.00947	0.146	CbGpPWpGaD
Cyclosporine—ABCB1—Dactinomycin—muscle cancer	0.00936	0.0127	CbGbCtD
Cyclosporine—CYP3A5—Vincristine—muscle cancer	0.00886	0.012	CbGbCtD
Cyclosporine—CYP3A5—Etoposide—muscle cancer	0.00812	0.011	CbGbCtD
Cyclosporine—SLC22A6—Methotrexate—muscle cancer	0.00783	0.0106	CbGbCtD
Cyclosporine—CYP2C8—Etoposide—muscle cancer	0.0078	0.0106	CbGbCtD
Cyclosporine—PPIA—APOBEC3G mediated resistance to HIV-1 infection—HMGA1—muscle cancer	0.00666	0.102	CbGpPWpGaD
Cyclosporine—ABCB1—Vincristine—muscle cancer	0.00577	0.00781	CbGbCtD
Cyclosporine—ABCB1—Etoposide—muscle cancer	0.00528	0.00715	CbGbCtD
Cyclosporine—PPIA—Integration of provirus—HMGA1—muscle cancer	0.00416	0.064	CbGpPWpGaD
Cyclosporine—PPID—C-MYB transcription factor network—MYOD1—muscle cancer	0.00377	0.0579	CbGpPWpGaD
Cyclosporine—PPID—C-MYB transcription factor network—CD34—muscle cancer	0.00377	0.0579	CbGpPWpGaD
Cyclosporine—ABCB1—Doxorubicin—muscle cancer	0.0036	0.00488	CbGbCtD
Cyclosporine—ABCB1—Methotrexate—muscle cancer	0.00349	0.00473	CbGbCtD
Cyclosporine—CYP3A4—Vincristine—muscle cancer	0.00345	0.00468	CbGbCtD
Cyclosporine—CYP2D6—Doxorubicin—muscle cancer	0.0034	0.0046	CbGbCtD
Cyclosporine—CYP3A4—Etoposide—muscle cancer	0.00317	0.00429	CbGbCtD
Cyclosporine—PPIA—Early Phase of HIV Life Cycle—HMGA1—muscle cancer	0.00292	0.0449	CbGpPWpGaD
Cyclosporine—PPP3R2—testis—muscle cancer	0.00281	0.0364	CbGeAlD
Cyclosporine—FKBP4—embryo—muscle cancer	0.00218	0.0283	CbGeAlD
Cyclosporine—CYP3A4—Doxorubicin—muscle cancer	0.00216	0.00292	CbGbCtD
Cyclosporine—PPP3CA—C-MYB transcription factor network—MYF6—muscle cancer	0.00192	0.0295	CbGpPWpGaD
Cyclosporine—FKBP1B—head—muscle cancer	0.00167	0.0217	CbGeAlD
Cyclosporine—SLC10A2—renal system—muscle cancer	0.00167	0.0216	CbGeAlD
Cyclosporine—FKBP4—renal system—muscle cancer	0.00165	0.0214	CbGeAlD
Cyclosporine—FKBP1B—testis—muscle cancer	0.00161	0.0209	CbGeAlD
Cyclosporine—PPID—smooth muscle tissue—muscle cancer	0.00158	0.0205	CbGeAlD
Cyclosporine—FKBP1A—TGF-beta Receptor Signaling—TFE3—muscle cancer	0.00153	0.0236	CbGpPWpGaD
Cyclosporine—PPID—renal system—muscle cancer	0.00152	0.0198	CbGeAlD
Cyclosporine—PPID—C-MYB transcription factor network—KIT—muscle cancer	0.00144	0.0222	CbGpPWpGaD
Cyclosporine—PPID—cardiac atrium—muscle cancer	0.00136	0.0177	CbGeAlD
Cyclosporine—CAMLG—cardiac atrium—muscle cancer	0.00134	0.0175	CbGeAlD
Cyclosporine—FKBP4—tendon—muscle cancer	0.00129	0.0167	CbGeAlD
Cyclosporine—SLC10A2—vagina—muscle cancer	0.00121	0.0157	CbGeAlD
Cyclosporine—PPID—tendon—muscle cancer	0.00119	0.0154	CbGeAlD
Cyclosporine—CAMLG—tendon—muscle cancer	0.00117	0.0152	CbGeAlD
Cyclosporine—PPID—C-MYB transcription factor network—CDKN2A—muscle cancer	0.00117	0.018	CbGpPWpGaD
Cyclosporine—PPID—bone marrow—muscle cancer	0.00115	0.0149	CbGeAlD
Cyclosporine—PPIF—smooth muscle tissue—muscle cancer	0.00115	0.0149	CbGeAlD
Cyclosporine—CAMLG—bone marrow—muscle cancer	0.00114	0.0147	CbGeAlD
Cyclosporine—PPIF—renal system—muscle cancer	0.00111	0.0144	CbGeAlD
Cyclosporine—FKBP4—head—muscle cancer	0.0011	0.0143	CbGeAlD
Cyclosporine—PPID—vagina—muscle cancer	0.0011	0.0143	CbGeAlD
Cyclosporine—PPP3CA—smooth muscle tissue—muscle cancer	0.0011	0.0143	CbGeAlD
Cyclosporine—PPIB—smooth muscle tissue—muscle cancer	0.0011	0.0142	CbGeAlD
Cyclosporine—PPID—C-MYB transcription factor network—PTGS2—muscle cancer	0.00109	0.0168	CbGpPWpGaD
Cyclosporine—CAMLG—vagina—muscle cancer	0.00109	0.0141	CbGeAlD
Cyclosporine—PPIA—tendon—muscle cancer	0.00107	0.0139	CbGeAlD
Cyclosporine—FKBP4—testis—muscle cancer	0.00107	0.0138	CbGeAlD
Cyclosporine—PPP3CA—renal system—muscle cancer	0.00106	0.0138	CbGeAlD
Cyclosporine—PPIB—renal system—muscle cancer	0.00105	0.0137	CbGeAlD
Cyclosporine—FKBP1B—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	0.00104	0.016	CbGpPWpGaD
Cyclosporine—PPIA—bone marrow—muscle cancer	0.00103	0.0134	CbGeAlD
Cyclosporine—PPID—head—muscle cancer	0.00102	0.0132	CbGeAlD
Cyclosporine—CAMLG—head—muscle cancer	0.001	0.013	CbGeAlD
Cyclosporine—PPIF—cardiac atrium—muscle cancer	0.000992	0.0129	CbGeAlD
Cyclosporine—PPIA—vagina—muscle cancer	0.000991	0.0129	CbGeAlD
Cyclosporine—PPID—testis—muscle cancer	0.000985	0.0128	CbGeAlD
Cyclosporine—CAMLG—testis—muscle cancer	0.000971	0.0126	CbGeAlD
Cyclosporine—PPP3CA—cardiac atrium—muscle cancer	0.00095	0.0123	CbGeAlD
Cyclosporine—PPIB—cardiac atrium—muscle cancer	0.000944	0.0123	CbGeAlD
Cyclosporine—PPIA—Cell surface interactions at the vascular wall—ANGPT2—muscle cancer	0.000905	0.0139	CbGpPWpGaD
Cyclosporine—SLC10A1—renal system—muscle cancer	0.000902	0.0117	CbGeAlD
Cyclosporine—PPIA—testis—muscle cancer	0.000884	0.0115	CbGeAlD
Cyclosporine—PPIF—tendon—muscle cancer	0.000865	0.0112	CbGeAlD
Cyclosporine—PPIF—bone marrow—muscle cancer	0.000838	0.0109	CbGeAlD
Cyclosporine—FKBP4—Androgen receptor signaling pathway—FOXO1—muscle cancer	0.00083	0.0127	CbGpPWpGaD
Cyclosporine—PPP3CA—tendon—muscle cancer	0.000828	0.0107	CbGeAlD
Cyclosporine—PPIB—tendon—muscle cancer	0.000823	0.0107	CbGeAlD
Cyclosporine—PPIF—vagina—muscle cancer	0.000802	0.0104	CbGeAlD
Cyclosporine—PPP3CA—bone marrow—muscle cancer	0.000802	0.0104	CbGeAlD
Cyclosporine—PPIB—bone marrow—muscle cancer	0.000797	0.0103	CbGeAlD
Cyclosporine—PPP3CA—vagina—muscle cancer	0.000768	0.00997	CbGeAlD
Cyclosporine—PPP3CA—C-MYB transcription factor network—CD34—muscle cancer	0.000764	0.0117	CbGpPWpGaD
Cyclosporine—PPP3CA—C-MYB transcription factor network—MYOD1—muscle cancer	0.000764	0.0117	CbGpPWpGaD
Cyclosporine—PPIB—vagina—muscle cancer	0.000764	0.00991	CbGeAlD
Cyclosporine—FKBP1B—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	0.000763	0.0117	CbGpPWpGaD
Cyclosporine—PPIB—Extracellular matrix organization—DMD—muscle cancer	0.000757	0.0116	CbGpPWpGaD
Cyclosporine—PPIF—head—muscle cancer	0.000741	0.00962	CbGeAlD
Cyclosporine—FKBP1A—smooth muscle tissue—muscle cancer	0.000732	0.0095	CbGeAlD
Cyclosporine—PPIF—testis—muscle cancer	0.000716	0.00929	CbGeAlD
Cyclosporine—PPP3CA—head—muscle cancer	0.00071	0.00921	CbGeAlD
Cyclosporine—PPIB—head—muscle cancer	0.000705	0.00915	CbGeAlD
Cyclosporine—FKBP1A—renal system—muscle cancer	0.000705	0.00914	CbGeAlD
Cyclosporine—FKBP4—Coregulation of Androgen receptor activity—CDKN2A—muscle cancer	0.000694	0.0107	CbGpPWpGaD
Cyclosporine—PPP3CA—testis—muscle cancer	0.000685	0.00889	CbGeAlD
Cyclosporine—PPIB—testis—muscle cancer	0.000681	0.00884	CbGeAlD
Cyclosporine—FKBP1A—cardiac atrium—muscle cancer	0.000631	0.00819	CbGeAlD
Cyclosporine—SLC10A1—head—muscle cancer	0.000603	0.00783	CbGeAlD
Cyclosporine—SLCO1B1—renal system—muscle cancer	0.000598	0.00776	CbGeAlD
Cyclosporine—SLC10A1—testis—muscle cancer	0.000583	0.00756	CbGeAlD
Cyclosporine—ABCB11—testis—muscle cancer	0.000576	0.00748	CbGeAlD
Cyclosporine—ABCC3—renal system—muscle cancer	0.000567	0.00736	CbGeAlD
Cyclosporine—ABCC10—renal system—muscle cancer	0.000565	0.00732	CbGeAlD
Cyclosporine—FKBP1A—tendon—muscle cancer	0.00055	0.00714	CbGeAlD
Cyclosporine—FKBP1A—bone marrow—muscle cancer	0.000533	0.00691	CbGeAlD
Cyclosporine—FKBP4—Glucocorticoid receptor regulatory network—MDM2—muscle cancer	0.000531	0.00817	CbGpPWpGaD
Cyclosporine—FKBP4—Cellular responses to stress—HMGA1—muscle cancer	0.000525	0.00806	CbGpPWpGaD
Cyclosporine—PPIA—Platelet degranulation—IGF2—muscle cancer	0.000522	0.00802	CbGpPWpGaD
Cyclosporine—FKBP1A—vagina—muscle cancer	0.00051	0.00662	CbGeAlD
Cyclosporine—ABCC10—cardiac atrium—muscle cancer	0.000506	0.00656	CbGeAlD
Cyclosporine—PPIA—Host Interactions of HIV factors—HMGA1—muscle cancer	0.000504	0.00775	CbGpPWpGaD
Cyclosporine—FKBP4—Androgen receptor signaling pathway—MDM2—muscle cancer	0.000498	0.00765	CbGpPWpGaD
Cyclosporine—PPIA—Response to elevated platelet cytosolic Ca2+—IGF2—muscle cancer	0.000497	0.00764	CbGpPWpGaD
Cyclosporine—SLCO1A2—renal system—muscle cancer	0.000487	0.00631	CbGeAlD
Cyclosporine—PPIA—HIV Life Cycle—HMGA1—muscle cancer	0.000474	0.00729	CbGpPWpGaD
Cyclosporine—FKBP1A—head—muscle cancer	0.000471	0.00612	CbGeAlD
Cyclosporine—FKBP1A—testis—muscle cancer	0.000455	0.00591	CbGeAlD
Cyclosporine—ABCC2—renal system—muscle cancer	0.000453	0.00588	CbGeAlD
Cyclosporine—PPP3R2—Alzheimers Disease—TP53—muscle cancer	0.000441	0.00678	CbGpPWpGaD
Cyclosporine—ABCC10—tendon—muscle cancer	0.000441	0.00572	CbGeAlD
Cyclosporine—ABCC10—bone marrow—muscle cancer	0.000427	0.00554	CbGeAlD
Cyclosporine—ABCC3—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000418	0.00643	CbGpPWpGaD
Cyclosporine—ABCC10—vagina—muscle cancer	0.000409	0.00531	CbGeAlD
Cyclosporine—FKBP1A—Calcium signaling in the CD4+ TCR pathway—PTGS2—muscle cancer	0.000403	0.00619	CbGpPWpGaD
Cyclosporine—ABCC3—head—muscle cancer	0.00038	0.00492	CbGeAlD
Cyclosporine—ABCC3—testis—muscle cancer	0.000367	0.00476	CbGeAlD
Cyclosporine—ABCC10—testis—muscle cancer	0.000365	0.00473	CbGeAlD
Cyclosporine—ABCC1—cardiac atrium—muscle cancer	0.000358	0.00464	CbGeAlD
Cyclosporine—ABCC2—tendon—muscle cancer	0.000354	0.00459	CbGeAlD
Cyclosporine—CYP2C8—renal system—muscle cancer	0.00034	0.00441	CbGeAlD
Cyclosporine—FKBP1B—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	0.000338	0.0052	CbGpPWpGaD
Cyclosporine—ABCC2—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000332	0.0051	CbGpPWpGaD
Cyclosporine—PPIA—HIV Infection—HMGA1—muscle cancer	0.000327	0.00503	CbGpPWpGaD
Cyclosporine—FKBP1B—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	0.000326	0.00501	CbGpPWpGaD
Cyclosporine—SLCO1A2—head—muscle cancer	0.000326	0.00422	CbGeAlD
Cyclosporine—SLCO1A2—testis—muscle cancer	0.000314	0.00408	CbGeAlD
Cyclosporine—ABCC1—tendon—muscle cancer	0.000312	0.00404	CbGeAlD
Cyclosporine—CYP3A5—renal system—muscle cancer	0.000307	0.00398	CbGeAlD
Cyclosporine—FKBP4—Glucocorticoid receptor regulatory network—TP53—muscle cancer	0.000305	0.00469	CbGpPWpGaD
Cyclosporine—ABCC2—testis—muscle cancer	0.000293	0.0038	CbGeAlD
Cyclosporine—PPP3CA—C-MYB transcription factor network—KIT—muscle cancer	0.000292	0.00449	CbGpPWpGaD
Cyclosporine—ABCC1—vagina—muscle cancer	0.000289	0.00375	CbGeAlD
Cyclosporine—ABCC1—S1P1 pathway—PTGS2—muscle cancer	0.000288	0.00442	CbGpPWpGaD
Cyclosporine—PPP3CA—Fc epsilon receptor (FCERI) signaling—FOXO4—muscle cancer	0.000286	0.0044	CbGpPWpGaD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	0.000286	0.00439	CbGpPWpGaD
Cyclosporine—CYP2C19—vagina—muscle cancer	0.000282	0.00366	CbGeAlD
Cyclosporine—ABCC1—testis—muscle cancer	0.000258	0.00335	CbGeAlD
Cyclosporine—FKBP1B—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	0.000257	0.00395	CbGpPWpGaD
Cyclosporine—ABCG2—bone marrow—muscle cancer	0.00025	0.00324	CbGeAlD
Cyclosporine—PPP3CA—Amyotrophic lateral sclerosis (ALS)—TP53—muscle cancer	0.000249	0.00383	CbGpPWpGaD
Cyclosporine—CYP2C8—vagina—muscle cancer	0.000246	0.00319	CbGeAlD
Cyclosporine—PPIA—Hemostasis—ANGPT2—muscle cancer	0.000245	0.00377	CbGpPWpGaD
Cyclosporine—PPP3R2—MAPK Signaling Pathway—TP53—muscle cancer	0.000241	0.00371	CbGpPWpGaD
Cyclosporine—ABCG2—vagina—muscle cancer	0.000239	0.00311	CbGeAlD
Cyclosporine—PPP3CA—C-MYB transcription factor network—CDKN2A—muscle cancer	0.000237	0.00365	CbGpPWpGaD
Cyclosporine—PPIA—Platelet activation, signaling and aggregation—IGF2—muscle cancer	0.000231	0.00356	CbGpPWpGaD
Cyclosporine—CYP3A4—renal system—muscle cancer	0.00023	0.00299	CbGeAlD
Cyclosporine—ABCC1—S1P1 pathway—VEGFA—muscle cancer	0.000227	0.00348	CbGpPWpGaD
Cyclosporine—CYP2D6—renal system—muscle cancer	0.000227	0.00294	CbGeAlD
Cyclosporine—CYP3A5—vagina—muscle cancer	0.000222	0.00288	CbGeAlD
Cyclosporine—PPP3CA—C-MYB transcription factor network—PTGS2—muscle cancer	0.000222	0.00341	CbGpPWpGaD
Cyclosporine—CYP2C8—testis—muscle cancer	0.00022	0.00285	CbGeAlD
Cyclosporine—PPIA—Platelet degranulation—VEGFA—muscle cancer	0.000219	0.00336	CbGpPWpGaD
Cyclosporine—ABCB1—embryo—muscle cancer	0.000215	0.00279	CbGeAlD
Cyclosporine—FKBP4—Cellular responses to stress—CDKN2A—muscle cancer	0.000215	0.00331	CbGpPWpGaD
Cyclosporine—ABCG2—testis—muscle cancer	0.000214	0.00277	CbGeAlD
Cyclosporine—PPP3CA—Fc epsilon receptor (FCERI) signaling—FOXO1—muscle cancer	0.000211	0.00325	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.000209	0.00322	CbGpPWpGaD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	0.000209	0.00321	CbGpPWpGaD
Cyclosporine—FKBP4—Cellular responses to stress—MDM2—muscle cancer	0.000209	0.00321	CbGpPWpGaD
Cyclosporine—PPIA—Response to elevated platelet cytosolic Ca2+—VEGFA—muscle cancer	0.000208	0.0032	CbGpPWpGaD
Cyclosporine—CYP3A5—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000207	0.00318	CbGpPWpGaD
Cyclosporine—FKBP1B—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	0.000194	0.00298	CbGpPWpGaD
Cyclosporine—CYP2C19—Melatonin metabolism and effects—FOXO1—muscle cancer	0.000173	0.00266	CbGpPWpGaD
Cyclosporine—PPP3CA—Spinal Cord Injury—PTGS2—muscle cancer	0.000169	0.0026	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism—FH—muscle cancer	0.000165	0.00254	CbGpPWpGaD
Cyclosporine—ABCB1—renal system—muscle cancer	0.000163	0.00211	CbGeAlD
Cyclosporine—PPP3CA—Fc epsilon receptor (FCERI) signaling—KIT—muscle cancer	0.000161	0.00248	CbGpPWpGaD
Cyclosporine—CYP2C19—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.00016	0.00246	CbGpPWpGaD
Cyclosporine—CYP2D6—Melatonin metabolism and effects—FOXO1—muscle cancer	0.000159	0.00244	CbGpPWpGaD
Cyclosporine—FKBP4—Cellular responses to stress—VEGFA—muscle cancer	0.000158	0.00243	CbGpPWpGaD
Cyclosporine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—muscle cancer	0.000156	0.0024	CbGpPWpGaD
Cyclosporine—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000156	0.0024	CbGpPWpGaD
Cyclosporine—CYP2D6—head—muscle cancer	0.000152	0.00197	CbGeAlD
Cyclosporine—Purpura—Doxorubicin—muscle cancer	0.000148	0.00125	CcSEcCtD
Cyclosporine—Body temperature increased—Dactinomycin—muscle cancer	0.000148	0.00124	CcSEcCtD
Cyclosporine—Abdominal pain—Dactinomycin—muscle cancer	0.000148	0.00124	CcSEcCtD
Cyclosporine—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.000148	0.00124	CcSEcCtD
Cyclosporine—Cardiac failure—Doxorubicin—muscle cancer	0.000147	0.00123	CcSEcCtD
Cyclosporine—Hypoglycaemia—Doxorubicin—muscle cancer	0.000147	0.00123	CcSEcCtD
Cyclosporine—CYP2D6—testis—muscle cancer	0.000146	0.0019	CbGeAlD
Cyclosporine—Lethargy—Doxorubicin—muscle cancer	0.000146	0.00123	CcSEcCtD
Cyclosporine—CYP2C9—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000146	0.00224	CbGpPWpGaD
Cyclosporine—Decreased appetite—Vincristine—muscle cancer	0.000146	0.00122	CcSEcCtD
Cyclosporine—Cough—Etoposide—muscle cancer	0.000145	0.00122	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Vincristine—muscle cancer	0.000145	0.00121	CcSEcCtD
Cyclosporine—Fatigue—Vincristine—muscle cancer	0.000144	0.00121	CcSEcCtD
Cyclosporine—Convulsion—Etoposide—muscle cancer	0.000144	0.00121	CcSEcCtD
Cyclosporine—Hypertension—Etoposide—muscle cancer	0.000143	0.0012	CcSEcCtD
Cyclosporine—Pain—Vincristine—muscle cancer	0.000143	0.0012	CcSEcCtD
Cyclosporine—Constipation—Vincristine—muscle cancer	0.000143	0.0012	CcSEcCtD
Cyclosporine—Osteoarthritis—Doxorubicin—muscle cancer	0.000143	0.0012	CcSEcCtD
Cyclosporine—Chest pain—Etoposide—muscle cancer	0.000141	0.00119	CcSEcCtD
Cyclosporine—Migraine—Doxorubicin—muscle cancer	0.000141	0.00118	CcSEcCtD
Cyclosporine—Affect lability—Doxorubicin—muscle cancer	0.000141	0.00118	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000141	0.00118	CcSEcCtD
Cyclosporine—ABCC3—Fluoropyrimidine Activity—TP53—muscle cancer	0.00014	0.00216	CbGpPWpGaD
Cyclosporine—Pancreatitis—Methotrexate—muscle cancer	0.00014	0.00117	CcSEcCtD
Cyclosporine—Discomfort—Etoposide—muscle cancer	0.00014	0.00117	CcSEcCtD
Cyclosporine—PPP3CA—Alzheimers Disease—TP53—muscle cancer	0.000139	0.00213	CbGpPWpGaD
Cyclosporine—Hypersensitivity—Dactinomycin—muscle cancer	0.000138	0.00116	CcSEcCtD
Cyclosporine—Abdominal discomfort—Methotrexate—muscle cancer	0.000137	0.00115	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Vincristine—muscle cancer	0.000137	0.00115	CcSEcCtD
Cyclosporine—Confusional state—Etoposide—muscle cancer	0.000137	0.00115	CcSEcCtD
Cyclosporine—Anaphylactic shock—Etoposide—muscle cancer	0.000136	0.00114	CcSEcCtD
Cyclosporine—Mood swings—Doxorubicin—muscle cancer	0.000136	0.00114	CcSEcCtD
Cyclosporine—SLC10A1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	0.000135	0.00207	CbGpPWpGaD
Cyclosporine—Infection—Etoposide—muscle cancer	0.000135	0.00113	CcSEcCtD
Cyclosporine—Asthenia—Dactinomycin—muscle cancer	0.000134	0.00113	CcSEcCtD
Cyclosporine—Blood creatinine increased—Doxorubicin—muscle cancer	0.000134	0.00112	CcSEcCtD
Cyclosporine—Dysuria—Methotrexate—muscle cancer	0.000134	0.00112	CcSEcCtD
Cyclosporine—Thrombocytopenia—Etoposide—muscle cancer	0.000133	0.00111	CcSEcCtD
Cyclosporine—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000133	0.00111	CcSEcCtD
Cyclosporine—ABCC1—Arachidonic acid metabolism—PTGS2—muscle cancer	0.000133	0.00204	CbGpPWpGaD
Cyclosporine—Body temperature increased—Vincristine—muscle cancer	0.000132	0.00111	CcSEcCtD
Cyclosporine—Abdominal pain—Vincristine—muscle cancer	0.000132	0.00111	CcSEcCtD
Cyclosporine—Skin disorder—Etoposide—muscle cancer	0.000132	0.0011	CcSEcCtD
Cyclosporine—Dry skin—Doxorubicin—muscle cancer	0.000131	0.0011	CcSEcCtD
Cyclosporine—FKBP1A—Spinal Cord Injury—PTGS2—muscle cancer	0.000131	0.00202	CbGpPWpGaD
Cyclosporine—Hyperhidrosis—Etoposide—muscle cancer	0.000131	0.0011	CcSEcCtD
Cyclosporine—Abdominal pain upper—Doxorubicin—muscle cancer	0.000131	0.0011	CcSEcCtD
Cyclosporine—Breast disorder—Doxorubicin—muscle cancer	0.000129	0.00108	CcSEcCtD
Cyclosporine—Anorexia—Etoposide—muscle cancer	0.000129	0.00108	CcSEcCtD
Cyclosporine—Diarrhoea—Dactinomycin—muscle cancer	0.000128	0.00108	CcSEcCtD
Cyclosporine—Pneumonia—Methotrexate—muscle cancer	0.000128	0.00107	CcSEcCtD
Cyclosporine—Infestation NOS—Methotrexate—muscle cancer	0.000127	0.00107	CcSEcCtD
Cyclosporine—Infestation—Methotrexate—muscle cancer	0.000127	0.00107	CcSEcCtD
Cyclosporine—Depression—Methotrexate—muscle cancer	0.000127	0.00107	CcSEcCtD
Cyclosporine—PPP3CA—Fc epsilon receptor (FCERI) signaling—MDM2—muscle cancer	0.000127	0.00195	CbGpPWpGaD
Cyclosporine—Gastritis—Doxorubicin—muscle cancer	0.000127	0.00106	CcSEcCtD
Cyclosporine—Muscular weakness—Doxorubicin—muscle cancer	0.000126	0.00106	CcSEcCtD
Cyclosporine—Renal failure—Methotrexate—muscle cancer	0.000125	0.00105	CcSEcCtD
Cyclosporine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—muscle cancer	0.000125	0.00192	CbGpPWpGaD
Cyclosporine—Abdominal distension—Doxorubicin—muscle cancer	0.000125	0.00104	CcSEcCtD
Cyclosporine—Stomatitis—Methotrexate—muscle cancer	0.000124	0.00104	CcSEcCtD
Cyclosporine—Conjunctivitis—Methotrexate—muscle cancer	0.000124	0.00104	CcSEcCtD
Cyclosporine—PPP3CA—Signaling Pathways—KIDINS220—muscle cancer	0.000124	0.0019	CbGpPWpGaD
Cyclosporine—Dysphagia—Doxorubicin—muscle cancer	0.000124	0.00104	CcSEcCtD
Cyclosporine—Hypersensitivity—Vincristine—muscle cancer	0.000123	0.00103	CcSEcCtD
Cyclosporine—ABCB1—bone marrow—muscle cancer	0.000123	0.0016	CbGeAlD
Cyclosporine—Paraesthesia—Etoposide—muscle cancer	0.000122	0.00102	CcSEcCtD
Cyclosporine—Haematuria—Methotrexate—muscle cancer	0.000121	0.00102	CcSEcCtD
Cyclosporine—Pancreatitis—Doxorubicin—muscle cancer	0.000121	0.00102	CcSEcCtD
Cyclosporine—Dyspnoea—Etoposide—muscle cancer	0.000121	0.00101	CcSEcCtD
Cyclosporine—Somnolence—Etoposide—muscle cancer	0.000121	0.00101	CcSEcCtD
Cyclosporine—Hepatobiliary disease—Methotrexate—muscle cancer	0.00012	0.00101	CcSEcCtD
Cyclosporine—Epistaxis—Methotrexate—muscle cancer	0.00012	0.00101	CcSEcCtD
Cyclosporine—Asthenia—Vincristine—muscle cancer	0.00012	0.00101	CcSEcCtD
Cyclosporine—FKBP4—Cellular responses to stress—TP53—muscle cancer	0.00012	0.00184	CbGpPWpGaD
Cyclosporine—PPIA—Hemostasis—IGF2—muscle cancer	0.000119	0.00183	CbGpPWpGaD
Cyclosporine—Vomiting—Dactinomycin—muscle cancer	0.000119	0.000999	CcSEcCtD
Cyclosporine—Bronchitis—Doxorubicin—muscle cancer	0.000119	0.000998	CcSEcCtD
Cyclosporine—Rash—Dactinomycin—muscle cancer	0.000118	0.000991	CcSEcCtD
Cyclosporine—ABCB1—vagina—muscle cancer	0.000118	0.00153	CbGeAlD
Cyclosporine—Decreased appetite—Etoposide—muscle cancer	0.000118	0.000989	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Etoposide—muscle cancer	0.000117	0.000982	CcSEcCtD
Cyclosporine—Fatigue—Etoposide—muscle cancer	0.000117	0.000981	CcSEcCtD
Cyclosporine—Pain—Etoposide—muscle cancer	0.000116	0.000973	CcSEcCtD
Cyclosporine—Constipation—Etoposide—muscle cancer	0.000116	0.000973	CcSEcCtD
Cyclosporine—Dysuria—Doxorubicin—muscle cancer	0.000116	0.00097	CcSEcCtD
Cyclosporine—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000115	0.000964	CcSEcCtD
Cyclosporine—Haemoglobin—Methotrexate—muscle cancer	0.000115	0.000964	CcSEcCtD
Cyclosporine—Diarrhoea—Vincristine—muscle cancer	0.000115	0.000961	CcSEcCtD
Cyclosporine—Hepatitis—Methotrexate—muscle cancer	0.000114	0.000959	CcSEcCtD
Cyclosporine—Haemorrhage—Methotrexate—muscle cancer	0.000114	0.000959	CcSEcCtD
Cyclosporine—Pollakiuria—Doxorubicin—muscle cancer	0.000114	0.000958	CcSEcCtD
Cyclosporine—Pharyngitis—Methotrexate—muscle cancer	0.000113	0.000952	CcSEcCtD
Cyclosporine—Urinary tract disorder—Methotrexate—muscle cancer	0.000113	0.000947	CcSEcCtD
Cyclosporine—Weight increased—Doxorubicin—muscle cancer	0.000113	0.000944	CcSEcCtD
Cyclosporine—Urethral disorder—Methotrexate—muscle cancer	0.000112	0.00094	CcSEcCtD
Cyclosporine—Weight decreased—Doxorubicin—muscle cancer	0.000112	0.000939	CcSEcCtD
Cyclosporine—Feeling abnormal—Etoposide—muscle cancer	0.000112	0.000937	CcSEcCtD
Cyclosporine—Hyperglycaemia—Doxorubicin—muscle cancer	0.000112	0.000936	CcSEcCtD
Cyclosporine—Nausea—Dactinomycin—muscle cancer	0.000111	0.000934	CcSEcCtD
Cyclosporine—PPP3CA—Innate Immune System—FOXO4—muscle cancer	0.000111	0.00171	CbGpPWpGaD
Cyclosporine—Pneumonia—Doxorubicin—muscle cancer	0.000111	0.00093	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Etoposide—muscle cancer	0.000111	0.00093	CcSEcCtD
Cyclosporine—Dizziness—Vincristine—muscle cancer	0.000111	0.000929	CcSEcCtD
Cyclosporine—Infestation—Doxorubicin—muscle cancer	0.00011	0.000925	CcSEcCtD
Cyclosporine—Infestation NOS—Doxorubicin—muscle cancer	0.00011	0.000925	CcSEcCtD
Cyclosporine—Visual impairment—Methotrexate—muscle cancer	0.00011	0.000924	CcSEcCtD
Cyclosporine—ABCB1—head—muscle cancer	0.000109	0.00141	CbGeAlD
Cyclosporine—Renal failure—Doxorubicin—muscle cancer	0.000108	0.000909	CcSEcCtD
Cyclosporine—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000108	0.000907	CcSEcCtD
Cyclosporine—Urticaria—Etoposide—muscle cancer	0.000108	0.000904	CcSEcCtD
Cyclosporine—Stomatitis—Doxorubicin—muscle cancer	0.000108	0.000902	CcSEcCtD
Cyclosporine—Jaundice—Doxorubicin—muscle cancer	0.000108	0.000902	CcSEcCtD
Cyclosporine—Body temperature increased—Etoposide—muscle cancer	0.000107	0.000899	CcSEcCtD
Cyclosporine—Abdominal pain—Etoposide—muscle cancer	0.000107	0.000899	CcSEcCtD
Cyclosporine—Conjunctivitis—Doxorubicin—muscle cancer	0.000107	0.000899	CcSEcCtD
Cyclosporine—Urinary tract infection—Doxorubicin—muscle cancer	0.000107	0.000899	CcSEcCtD
Cyclosporine—Tinnitus—Methotrexate—muscle cancer	0.000107	0.000894	CcSEcCtD
Cyclosporine—Vomiting—Vincristine—muscle cancer	0.000106	0.000893	CcSEcCtD
Cyclosporine—SLC10A1—Metabolism—FH—muscle cancer	0.000106	0.00163	CbGpPWpGaD
Cyclosporine—Rash—Vincristine—muscle cancer	0.000106	0.000885	CcSEcCtD
Cyclosporine—Dermatitis—Vincristine—muscle cancer	0.000105	0.000885	CcSEcCtD
Cyclosporine—ABCB1—testis—muscle cancer	0.000105	0.00137	CbGeAlD
Cyclosporine—Haematuria—Doxorubicin—muscle cancer	0.000105	0.000882	CcSEcCtD
Cyclosporine—Headache—Vincristine—muscle cancer	0.000105	0.00088	CcSEcCtD
Cyclosporine—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000104	0.000875	CcSEcCtD
Cyclosporine—Epistaxis—Doxorubicin—muscle cancer	0.000104	0.000873	CcSEcCtD
Cyclosporine—Angiopathy—Methotrexate—muscle cancer	0.000104	0.00087	CcSEcCtD
Cyclosporine—Sinusitis—Doxorubicin—muscle cancer	0.000103	0.000868	CcSEcCtD
Cyclosporine—Mediastinal disorder—Methotrexate—muscle cancer	0.000103	0.000864	CcSEcCtD
Cyclosporine—Chills—Methotrexate—muscle cancer	0.000103	0.000861	CcSEcCtD
Cyclosporine—Alopecia—Methotrexate—muscle cancer	0.000101	0.000847	CcSEcCtD
Cyclosporine—PPP3CA—Spinal Cord Injury—TP53—muscle cancer	0.000101	0.00155	CbGpPWpGaD
Cyclosporine—Mental disorder—Methotrexate—muscle cancer	0.0001	0.00084	CcSEcCtD
Cyclosporine—Hypersensitivity—Etoposide—muscle cancer	9.99e-05	0.000838	CcSEcCtD
Cyclosporine—Malnutrition—Methotrexate—muscle cancer	9.95e-05	0.000835	CcSEcCtD
Cyclosporine—Haemoglobin—Doxorubicin—muscle cancer	9.95e-05	0.000835	CcSEcCtD
Cyclosporine—Nausea—Vincristine—muscle cancer	9.95e-05	0.000834	CcSEcCtD
Cyclosporine—Rhinitis—Doxorubicin—muscle cancer	9.93e-05	0.000833	CcSEcCtD
Cyclosporine—Hepatitis—Doxorubicin—muscle cancer	9.9e-05	0.00083	CcSEcCtD
Cyclosporine—Haemorrhage—Doxorubicin—muscle cancer	9.9e-05	0.00083	CcSEcCtD
Cyclosporine—Hypoaesthesia—Doxorubicin—muscle cancer	9.85e-05	0.000826	CcSEcCtD
Cyclosporine—Pharyngitis—Doxorubicin—muscle cancer	9.83e-05	0.000824	CcSEcCtD
Cyclosporine—Urinary tract disorder—Doxorubicin—muscle cancer	9.78e-05	0.00082	CcSEcCtD
Cyclosporine—Dysgeusia—Methotrexate—muscle cancer	9.75e-05	0.000818	CcSEcCtD
Cyclosporine—Asthenia—Etoposide—muscle cancer	9.73e-05	0.000816	CcSEcCtD
Cyclosporine—Connective tissue disorder—Doxorubicin—muscle cancer	9.73e-05	0.000816	CcSEcCtD
Cyclosporine—Urethral disorder—Doxorubicin—muscle cancer	9.71e-05	0.000814	CcSEcCtD
Cyclosporine—PPIA—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	9.7e-05	0.00149	CbGpPWpGaD
Cyclosporine—ABCG2—Fluoropyrimidine Activity—TP53—muscle cancer	9.69e-05	0.00149	CbGpPWpGaD
Cyclosporine—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	9.61e-05	0.00148	CbGpPWpGaD
Cyclosporine—Pruritus—Etoposide—muscle cancer	9.6e-05	0.000805	CcSEcCtD
Cyclosporine—FKBP1A—Signaling Pathways—KIDINS220—muscle cancer	9.59e-05	0.00147	CbGpPWpGaD
Cyclosporine—Visual impairment—Doxorubicin—muscle cancer	9.54e-05	0.0008	CcSEcCtD
Cyclosporine—PPP3CA—Immune System—CD34—muscle cancer	9.53e-05	0.00146	CbGpPWpGaD
Cyclosporine—Vision blurred—Methotrexate—muscle cancer	9.38e-05	0.000787	CcSEcCtD
Cyclosporine—SLC10A2—Metabolism—MED12—muscle cancer	9.32e-05	0.00143	CbGpPWpGaD
Cyclosporine—Diarrhoea—Etoposide—muscle cancer	9.28e-05	0.000778	CcSEcCtD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	9.25e-05	0.00142	CbGpPWpGaD
Cyclosporine—Ill-defined disorder—Methotrexate—muscle cancer	9.24e-05	0.000775	CcSEcCtD
Cyclosporine—Tinnitus—Doxorubicin—muscle cancer	9.23e-05	0.000774	CcSEcCtD
Cyclosporine—Anaemia—Methotrexate—muscle cancer	9.2e-05	0.000772	CcSEcCtD
Cyclosporine—Flushing—Doxorubicin—muscle cancer	9.19e-05	0.000771	CcSEcCtD
Cyclosporine—Angiopathy—Doxorubicin—muscle cancer	8.98e-05	0.000753	CcSEcCtD
Cyclosporine—Malaise—Methotrexate—muscle cancer	8.98e-05	0.000753	CcSEcCtD
Cyclosporine—Dizziness—Etoposide—muscle cancer	8.97e-05	0.000752	CcSEcCtD
Cyclosporine—Vertigo—Methotrexate—muscle cancer	8.94e-05	0.00075	CcSEcCtD
Cyclosporine—Mediastinal disorder—Doxorubicin—muscle cancer	8.92e-05	0.000748	CcSEcCtD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	8.92e-05	0.00137	CbGpPWpGaD
Cyclosporine—Leukopenia—Methotrexate—muscle cancer	8.91e-05	0.000747	CcSEcCtD
Cyclosporine—Chills—Doxorubicin—muscle cancer	8.88e-05	0.000745	CcSEcCtD
Cyclosporine—Arrhythmia—Doxorubicin—muscle cancer	8.85e-05	0.000742	CcSEcCtD
Cyclosporine—PPIA—Disease—ENO2—muscle cancer	8.83e-05	0.00136	CbGpPWpGaD
Cyclosporine—Alopecia—Doxorubicin—muscle cancer	8.75e-05	0.000734	CcSEcCtD
Cyclosporine—Cough—Methotrexate—muscle cancer	8.69e-05	0.000729	CcSEcCtD
Cyclosporine—Mental disorder—Doxorubicin—muscle cancer	8.67e-05	0.000728	CcSEcCtD
Cyclosporine—Convulsion—Methotrexate—muscle cancer	8.62e-05	0.000723	CcSEcCtD
Cyclosporine—Vomiting—Etoposide—muscle cancer	8.62e-05	0.000723	CcSEcCtD
Cyclosporine—Malnutrition—Doxorubicin—muscle cancer	8.62e-05	0.000723	CcSEcCtD
Cyclosporine—Rash—Etoposide—muscle cancer	8.55e-05	0.000717	CcSEcCtD
Cyclosporine—Dermatitis—Etoposide—muscle cancer	8.54e-05	0.000717	CcSEcCtD
Cyclosporine—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—muscle cancer	8.52e-05	0.00131	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism—ENO2—muscle cancer	8.5e-05	0.00131	CbGpPWpGaD
Cyclosporine—Headache—Etoposide—muscle cancer	8.5e-05	0.000713	CcSEcCtD
Cyclosporine—Flatulence—Doxorubicin—muscle cancer	8.49e-05	0.000712	CcSEcCtD
Cyclosporine—Chest pain—Methotrexate—muscle cancer	8.47e-05	0.000711	CcSEcCtD
Cyclosporine—Arthralgia—Methotrexate—muscle cancer	8.47e-05	0.000711	CcSEcCtD
Cyclosporine—Myalgia—Methotrexate—muscle cancer	8.47e-05	0.000711	CcSEcCtD
Cyclosporine—Tension—Doxorubicin—muscle cancer	8.46e-05	0.000709	CcSEcCtD
Cyclosporine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—muscle cancer	8.45e-05	0.0013	CbGpPWpGaD
Cyclosporine—Dysgeusia—Doxorubicin—muscle cancer	8.44e-05	0.000708	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	8.42e-05	0.000706	CcSEcCtD
Cyclosporine—Discomfort—Methotrexate—muscle cancer	8.37e-05	0.000702	CcSEcCtD
Cyclosporine—Nervousness—Doxorubicin—muscle cancer	8.37e-05	0.000702	CcSEcCtD
Cyclosporine—Muscle spasms—Doxorubicin—muscle cancer	8.29e-05	0.000695	CcSEcCtD
Cyclosporine—PPP3CA—Signaling by GPCR—PTCH1—muscle cancer	8.24e-05	0.00127	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—FOXO1—muscle cancer	8.21e-05	0.00126	CbGpPWpGaD
Cyclosporine—Confusional state—Methotrexate—muscle cancer	8.19e-05	0.000687	CcSEcCtD
Cyclosporine—Anaphylactic shock—Methotrexate—muscle cancer	8.12e-05	0.000681	CcSEcCtD
Cyclosporine—Vision blurred—Doxorubicin—muscle cancer	8.12e-05	0.000681	CcSEcCtD
Cyclosporine—Infection—Methotrexate—muscle cancer	8.07e-05	0.000677	CcSEcCtD
Cyclosporine—Nausea—Etoposide—muscle cancer	8.06e-05	0.000676	CcSEcCtD
Cyclosporine—PPIA—Disease—HMGA1—muscle cancer	8.02e-05	0.00123	CbGpPWpGaD
Cyclosporine—Ill-defined disorder—Doxorubicin—muscle cancer	8e-05	0.000671	CcSEcCtD
Cyclosporine—Nervous system disorder—Methotrexate—muscle cancer	7.97e-05	0.000668	CcSEcCtD
Cyclosporine—Anaemia—Doxorubicin—muscle cancer	7.97e-05	0.000668	CcSEcCtD
Cyclosporine—Thrombocytopenia—Methotrexate—muscle cancer	7.95e-05	0.000667	CcSEcCtD
Cyclosporine—ABCB11—Metabolism of lipids and lipoproteins—MED12—muscle cancer	7.95e-05	0.00122	CbGpPWpGaD
Cyclosporine—Agitation—Doxorubicin—muscle cancer	7.92e-05	0.000664	CcSEcCtD
Cyclosporine—Skin disorder—Methotrexate—muscle cancer	7.89e-05	0.000662	CcSEcCtD
Cyclosporine—Hyperhidrosis—Methotrexate—muscle cancer	7.85e-05	0.000659	CcSEcCtD
Cyclosporine—FKBP1A—Spinal Cord Injury—TP53—muscle cancer	7.81e-05	0.0012	CbGpPWpGaD
Cyclosporine—Malaise—Doxorubicin—muscle cancer	7.77e-05	0.000652	CcSEcCtD
Cyclosporine—Vertigo—Doxorubicin—muscle cancer	7.74e-05	0.00065	CcSEcCtD
Cyclosporine—Anorexia—Methotrexate—muscle cancer	7.74e-05	0.000649	CcSEcCtD
Cyclosporine—Leukopenia—Doxorubicin—muscle cancer	7.72e-05	0.000647	CcSEcCtD
Cyclosporine—ABCC3—Metabolism of lipids and lipoproteins—MED12—muscle cancer	7.62e-05	0.00117	CbGpPWpGaD
Cyclosporine—PPP3CA—MAPK Signaling Pathway—TP53—muscle cancer	7.59e-05	0.00117	CbGpPWpGaD
Cyclosporine—Cough—Doxorubicin—muscle cancer	7.52e-05	0.000631	CcSEcCtD
Cyclosporine—Convulsion—Doxorubicin—muscle cancer	7.47e-05	0.000626	CcSEcCtD
Cyclosporine—Hypertension—Doxorubicin—muscle cancer	7.44e-05	0.000624	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Methotrexate—muscle cancer	7.4e-05	0.000621	CcSEcCtD
Cyclosporine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	7.36e-05	0.00113	CbGpPWpGaD
Cyclosporine—Insomnia—Methotrexate—muscle cancer	7.35e-05	0.000616	CcSEcCtD
Cyclosporine—Arthralgia—Doxorubicin—muscle cancer	7.34e-05	0.000615	CcSEcCtD
Cyclosporine—Chest pain—Doxorubicin—muscle cancer	7.34e-05	0.000615	CcSEcCtD
Cyclosporine—Myalgia—Doxorubicin—muscle cancer	7.34e-05	0.000615	CcSEcCtD
Cyclosporine—PPP3CA—Disease—ENO2—muscle cancer	7.34e-05	0.00113	CbGpPWpGaD
Cyclosporine—Anxiety—Doxorubicin—muscle cancer	7.31e-05	0.000613	CcSEcCtD
Cyclosporine—Paraesthesia—Methotrexate—muscle cancer	7.29e-05	0.000612	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	7.29e-05	0.000611	CcSEcCtD
Cyclosporine—Discomfort—Doxorubicin—muscle cancer	7.25e-05	0.000608	CcSEcCtD
Cyclosporine—CYP2C8—Arachidonic acid metabolism—PTGS2—muscle cancer	7.24e-05	0.00111	CbGpPWpGaD
Cyclosporine—Dyspnoea—Methotrexate—muscle cancer	7.24e-05	0.000607	CcSEcCtD
Cyclosporine—Somnolence—Methotrexate—muscle cancer	7.22e-05	0.000606	CcSEcCtD
Cyclosporine—PPIA—Disease—FOXO4—muscle cancer	7.2e-05	0.00111	CbGpPWpGaD
Cyclosporine—Dry mouth—Doxorubicin—muscle cancer	7.18e-05	0.000602	CcSEcCtD
Cyclosporine—Dyspepsia—Methotrexate—muscle cancer	7.15e-05	0.0006	CcSEcCtD
Cyclosporine—Confusional state—Doxorubicin—muscle cancer	7.09e-05	0.000595	CcSEcCtD
Cyclosporine—Decreased appetite—Methotrexate—muscle cancer	7.06e-05	0.000592	CcSEcCtD
Cyclosporine—Oedema—Doxorubicin—muscle cancer	7.03e-05	0.00059	CcSEcCtD
Cyclosporine—Anaphylactic shock—Doxorubicin—muscle cancer	7.03e-05	0.00059	CcSEcCtD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	7.03e-05	0.00108	CbGpPWpGaD
Cyclosporine—Gastrointestinal disorder—Methotrexate—muscle cancer	7.01e-05	0.000588	CcSEcCtD
Cyclosporine—Fatigue—Methotrexate—muscle cancer	7e-05	0.000587	CcSEcCtD
Cyclosporine—Infection—Doxorubicin—muscle cancer	6.99e-05	0.000586	CcSEcCtD
Cyclosporine—PPP3CA—Signaling by GPCR—CNR1—muscle cancer	6.96e-05	0.00107	CbGpPWpGaD
Cyclosporine—Pain—Methotrexate—muscle cancer	6.95e-05	0.000583	CcSEcCtD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	6.91e-05	0.00106	CbGpPWpGaD
Cyclosporine—Nervous system disorder—Doxorubicin—muscle cancer	6.9e-05	0.000579	CcSEcCtD
Cyclosporine—Thrombocytopenia—Doxorubicin—muscle cancer	6.89e-05	0.000578	CcSEcCtD
Cyclosporine—Skin disorder—Doxorubicin—muscle cancer	6.83e-05	0.000573	CcSEcCtD
Cyclosporine—Hyperhidrosis—Doxorubicin—muscle cancer	6.8e-05	0.00057	CcSEcCtD
Cyclosporine—Anorexia—Doxorubicin—muscle cancer	6.71e-05	0.000562	CcSEcCtD
Cyclosporine—Feeling abnormal—Methotrexate—muscle cancer	6.69e-05	0.000561	CcSEcCtD
Cyclosporine—PPP3CA—Disease—HMGA1—muscle cancer	6.67e-05	0.00102	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	6.65e-05	0.00102	CbGpPWpGaD
Cyclosporine—Gastrointestinal pain—Methotrexate—muscle cancer	6.64e-05	0.000557	CcSEcCtD
Cyclosporine—SLCO1A2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	6.64e-05	0.00102	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—FOXO4—muscle cancer	6.48e-05	0.000995	CbGpPWpGaD
Cyclosporine—CYP2C19—Arachidonic acid metabolism—PTGS2—muscle cancer	6.47e-05	0.000994	CbGpPWpGaD
Cyclosporine—Urticaria—Methotrexate—muscle cancer	6.45e-05	0.000541	CcSEcCtD
Cyclosporine—Abdominal pain—Methotrexate—muscle cancer	6.42e-05	0.000539	CcSEcCtD
Cyclosporine—Body temperature increased—Methotrexate—muscle cancer	6.42e-05	0.000539	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	6.41e-05	0.000538	CcSEcCtD
Cyclosporine—Insomnia—Doxorubicin—muscle cancer	6.36e-05	0.000534	CcSEcCtD
Cyclosporine—Paraesthesia—Doxorubicin—muscle cancer	6.32e-05	0.00053	CcSEcCtD
Cyclosporine—Dyspnoea—Doxorubicin—muscle cancer	6.27e-05	0.000526	CcSEcCtD
Cyclosporine—ABCB11—Metabolism—FH—muscle cancer	6.26e-05	0.000963	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—KIT—muscle cancer	6.26e-05	0.000962	CbGpPWpGaD
Cyclosporine—Somnolence—Doxorubicin—muscle cancer	6.25e-05	0.000525	CcSEcCtD
Cyclosporine—Dyspepsia—Doxorubicin—muscle cancer	6.19e-05	0.000519	CcSEcCtD
Cyclosporine—Decreased appetite—Doxorubicin—muscle cancer	6.12e-05	0.000513	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Doxorubicin—muscle cancer	6.07e-05	0.000509	CcSEcCtD
Cyclosporine—Fatigue—Doxorubicin—muscle cancer	6.06e-05	0.000509	CcSEcCtD
Cyclosporine—Pain—Doxorubicin—muscle cancer	6.02e-05	0.000505	CcSEcCtD
Cyclosporine—Constipation—Doxorubicin—muscle cancer	6.02e-05	0.000505	CcSEcCtD
Cyclosporine—ABCC3—Metabolism—FH—muscle cancer	6.01e-05	0.000923	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—MED12—muscle cancer	6.01e-05	0.000923	CbGpPWpGaD
Cyclosporine—Hypersensitivity—Methotrexate—muscle cancer	5.99e-05	0.000502	CcSEcCtD
Cyclosporine—PPP3CA—Disease—FOXO4—muscle cancer	5.98e-05	0.000919	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	5.97e-05	0.000918	CbGpPWpGaD
Cyclosporine—CYP2C9—Arachidonic acid metabolism—PTGS2—muscle cancer	5.9e-05	0.000906	CbGpPWpGaD
Cyclosporine—Asthenia—Methotrexate—muscle cancer	5.83e-05	0.000489	CcSEcCtD
Cyclosporine—Feeling abnormal—Doxorubicin—muscle cancer	5.8e-05	0.000486	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Doxorubicin—muscle cancer	5.75e-05	0.000482	CcSEcCtD
Cyclosporine—Pruritus—Methotrexate—muscle cancer	5.75e-05	0.000482	CcSEcCtD
Cyclosporine—FKBP1A—Disease—ENO2—muscle cancer	5.69e-05	0.000874	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	5.67e-05	0.000872	CbGpPWpGaD
Cyclosporine—Urticaria—Doxorubicin—muscle cancer	5.59e-05	0.000469	CcSEcCtD
Cyclosporine—Abdominal pain—Doxorubicin—muscle cancer	5.56e-05	0.000466	CcSEcCtD
Cyclosporine—Body temperature increased—Doxorubicin—muscle cancer	5.56e-05	0.000466	CcSEcCtD
Cyclosporine—Diarrhoea—Methotrexate—muscle cancer	5.56e-05	0.000466	CcSEcCtD
Cyclosporine—SLC10A1—Metabolism—ENO2—muscle cancer	5.48e-05	0.000842	CbGpPWpGaD
Cyclosporine—Dizziness—Methotrexate—muscle cancer	5.37e-05	0.000451	CcSEcCtD
Cyclosporine—PPIA—Disease—FOXO1—muscle cancer	5.31e-05	0.000817	CbGpPWpGaD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	5.31e-05	0.000816	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—FH—muscle cancer	5.23e-05	0.000804	CbGpPWpGaD
Cyclosporine—Hypersensitivity—Doxorubicin—muscle cancer	5.18e-05	0.000435	CcSEcCtD
Cyclosporine—FKBP1A—Disease—HMGA1—muscle cancer	5.17e-05	0.000795	CbGpPWpGaD
Cyclosporine—Vomiting—Methotrexate—muscle cancer	5.17e-05	0.000433	CcSEcCtD
Cyclosporine—Rash—Methotrexate—muscle cancer	5.12e-05	0.00043	CcSEcCtD
Cyclosporine—Dermatitis—Methotrexate—muscle cancer	5.12e-05	0.000429	CcSEcCtD
Cyclosporine—Headache—Methotrexate—muscle cancer	5.09e-05	0.000427	CcSEcCtD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	5.06e-05	0.000777	CbGpPWpGaD
Cyclosporine—Asthenia—Doxorubicin—muscle cancer	5.05e-05	0.000423	CcSEcCtD
Cyclosporine—PPIA—Hemostasis—VEGFA—muscle cancer	5e-05	0.000769	CbGpPWpGaD
Cyclosporine—Pruritus—Doxorubicin—muscle cancer	4.98e-05	0.000417	CcSEcCtD
Cyclosporine—PPP3CA—Innate Immune System—MDM2—muscle cancer	4.93e-05	0.000757	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—PTCH1—muscle cancer	4.87e-05	0.000748	CbGpPWpGaD
Cyclosporine—Nausea—Methotrexate—muscle cancer	4.83e-05	0.000405	CcSEcCtD
Cyclosporine—Diarrhoea—Doxorubicin—muscle cancer	4.81e-05	0.000404	CcSEcCtD
Cyclosporine—PPP3CA—Immune System—FOXO1—muscle cancer	4.78e-05	0.000735	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—FH—muscle cancer	4.71e-05	0.000723	CbGpPWpGaD
Cyclosporine—Dizziness—Doxorubicin—muscle cancer	4.65e-05	0.00039	CcSEcCtD
Cyclosporine—FKBP1A—Disease—FOXO4—muscle cancer	4.64e-05	0.000713	CbGpPWpGaD
Cyclosporine—Vomiting—Doxorubicin—muscle cancer	4.47e-05	0.000375	CcSEcCtD
Cyclosporine—SLCO1B1—Metabolism—FH—muscle cancer	4.47e-05	0.000687	CbGpPWpGaD
Cyclosporine—Rash—Doxorubicin—muscle cancer	4.44e-05	0.000372	CcSEcCtD
Cyclosporine—Dermatitis—Doxorubicin—muscle cancer	4.43e-05	0.000372	CcSEcCtD
Cyclosporine—PPP3CA—Disease—FOXO1—muscle cancer	4.42e-05	0.000679	CbGpPWpGaD
Cyclosporine—Headache—Doxorubicin—muscle cancer	4.41e-05	0.00037	CcSEcCtD
Cyclosporine—CYP3A4—Tryptophan metabolism—MDM2—muscle cancer	4.31e-05	0.000663	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	4.28e-05	0.000658	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—FOXO4—muscle cancer	4.19e-05	0.000644	CbGpPWpGaD
Cyclosporine—Nausea—Doxorubicin—muscle cancer	4.18e-05	0.00035	CcSEcCtD
Cyclosporine—ABCG2—Metabolism—FH—muscle cancer	4.14e-05	0.000636	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CNR1—muscle cancer	4.11e-05	0.000632	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—FH—muscle cancer	4.1e-05	0.000631	CbGpPWpGaD
Cyclosporine—PPIA—Disease—KIT—muscle cancer	4.05e-05	0.000622	CbGpPWpGaD
Cyclosporine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	3.98e-05	0.000612	CbGpPWpGaD
Cyclosporine—PPIA—Hemostasis—TP53—muscle cancer	3.78e-05	0.000581	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—PTCH1—muscle cancer	3.78e-05	0.00058	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—KIT—muscle cancer	3.64e-05	0.00056	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—MED12—muscle cancer	3.54e-05	0.000544	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—VEGFA—muscle cancer	3.45e-05	0.00053	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—FOXO1—muscle cancer	3.42e-05	0.000526	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—MED12—muscle cancer	3.39e-05	0.000522	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—KIT—muscle cancer	3.37e-05	0.000517	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—IGF2—muscle cancer	3.36e-05	0.000516	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—MED12—muscle cancer	3.26e-05	0.000501	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—FOXO4—muscle cancer	3.25e-05	0.000499	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—ENO2—muscle cancer	3.23e-05	0.000496	CbGpPWpGaD
Cyclosporine—PPIA—Disease—MDM2—muscle cancer	3.19e-05	0.00049	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CNR1—muscle cancer	3.19e-05	0.00049	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—ENO2—muscle cancer	3.09e-05	0.000476	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—FOXO1—muscle cancer	3.09e-05	0.000475	CbGpPWpGaD
Cyclosporine—PPIA—Disease—PTGS2—muscle cancer	3.07e-05	0.000472	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—FH—muscle cancer	2.97e-05	0.000456	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism—PTGS2—muscle cancer	2.96e-05	0.000455	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—MED12—muscle cancer	2.95e-05	0.000454	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—MED12—muscle cancer	2.91e-05	0.000447	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—ENO2—muscle cancer	2.89e-05	0.000445	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—MDM2—muscle cancer	2.87e-05	0.000441	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—ENO2—muscle cancer	2.69e-05	0.000414	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—MED12—muscle cancer	2.66e-05	0.000409	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—MED12—muscle cancer	2.65e-05	0.000408	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—MDM2—muscle cancer	2.65e-05	0.000407	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—HMGA1—muscle cancer	2.63e-05	0.000404	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—KIT—muscle cancer	2.61e-05	0.000401	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—IGF2—muscle cancer	2.61e-05	0.0004	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—FH—muscle cancer	2.57e-05	0.000395	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—PTGS2—muscle cancer	2.55e-05	0.000393	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—MED12—muscle cancer	2.53e-05	0.000388	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.52e-05	0.000388	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—ENO2—muscle cancer	2.42e-05	0.000373	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.42e-05	0.000372	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—FOXO1—muscle cancer	2.4e-05	0.000369	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—FOXO4—muscle cancer	2.36e-05	0.000363	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—KIT—muscle cancer	2.36e-05	0.000362	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—MED12—muscle cancer	2.34e-05	0.00036	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—MED12—muscle cancer	2.32e-05	0.000356	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—ENO2—muscle cancer	2.3e-05	0.000354	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—FH—muscle cancer	2.29e-05	0.000353	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	2.24e-05	0.000344	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—FH—muscle cancer	2.24e-05	0.000344	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	2.16e-05	0.000332	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—ENO2—muscle cancer	2.13e-05	0.000328	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—ENO2—muscle cancer	2.11e-05	0.000325	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—FH—muscle cancer	2.11e-05	0.000324	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.11e-05	0.000324	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—FH—muscle cancer	2.09e-05	0.000321	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—MDM2—muscle cancer	2.05e-05	0.000316	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—PTGS2—muscle cancer	1.98e-05	0.000304	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—PTGS2—muscle cancer	1.91e-05	0.000293	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.9e-05	0.000291	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—MDM2—muscle cancer	1.86e-05	0.000285	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—KIT—muscle cancer	1.83e-05	0.000281	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.8e-05	0.000277	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—FOXO1—muscle cancer	1.74e-05	0.000268	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	1.7e-05	0.000262	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—MED12—muscle cancer	1.68e-05	0.000258	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—ENO2—muscle cancer	1.53e-05	0.000235	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—MED12—muscle cancer	1.45e-05	0.000223	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MDM2—muscle cancer	1.44e-05	0.000221	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—VEGFA—muscle cancer	1.41e-05	0.000217	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—FH—muscle cancer	1.38e-05	0.000212	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—KIT—muscle cancer	1.33e-05	0.000204	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—ENO2—muscle cancer	1.32e-05	0.000203	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—MED12—muscle cancer	1.3e-05	0.000199	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	1.29e-05	0.000198	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—MED12—muscle cancer	1.27e-05	0.000194	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—MED12—muscle cancer	1.19e-05	0.000183	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—MED12—muscle cancer	1.18e-05	0.000182	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—ENO2—muscle cancer	1.18e-05	0.000182	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—ENO2—muscle cancer	1.15e-05	0.000177	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PTGS2—muscle cancer	1.12e-05	0.000173	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—VEGFA—muscle cancer	1.09e-05	0.000168	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ENO2—muscle cancer	1.09e-05	0.000167	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PTGS2—muscle cancer	1.08e-05	0.000166	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ENO2—muscle cancer	1.08e-05	0.000166	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—TP53—muscle cancer	1.06e-05	0.000164	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MDM2—muscle cancer	1.05e-05	0.000161	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.04e-05	0.000159	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PTGS2—muscle cancer	1.01e-05	0.000155	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PTGS2—muscle cancer	9.38e-06	0.000144	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	9.24e-06	0.000142	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PTGS2—muscle cancer	8.44e-06	0.00013	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	8.43e-06	0.00013	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—TP53—muscle cancer	8.26e-06	0.000127	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PTGS2—muscle cancer	8.02e-06	0.000123	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—MED12—muscle cancer	7.79e-06	0.00012	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PTGS2—muscle cancer	7.43e-06	0.000114	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PTGS2—muscle cancer	7.36e-06	0.000113	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ENO2—muscle cancer	7.11e-06	0.000109	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PTGS2—muscle cancer	5.32e-06	8.18e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PTGS2—muscle cancer	4.61e-06	7.09e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PTGS2—muscle cancer	4.12e-06	6.33e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PTGS2—muscle cancer	4.02e-06	6.17e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PTGS2—muscle cancer	3.79e-06	5.82e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PTGS2—muscle cancer	3.75e-06	5.77e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PTGS2—muscle cancer	2.47e-06	3.8e-05	CbGpPWpGaD
